Timing of ASD Closure in Neonates
Most neonates with isolated atrial septal defects do not require closure during the neonatal period or infancy, with elective closure typically performed between ages 2-5 years when the child is symptomatic with right ventricular volume overload. However, symptomatic neonates and infants with specific high-risk features require earlier intervention, sometimes within the first year of life.
Standard Timing for Asymptomatic ASD
- Closure should be performed once right ventricular volume overload is documented, regardless of symptoms, with optimal outcomes achieved when repair occurs before age 25 years 1
- The traditional approach delays closure until ages 4-5 years for isolated secundum ASDs in asymptomatic children 2
- Device closure can be successfully performed in children as young as 2 years of age, though a weight of 15 kg offers technical advantages 3
Indications for Early Closure in Neonates and Infants
Early surgical closure within the first 1-2 years of life is indicated when neonates or infants are symptomatic despite the general preference to wait 2, 4. Specific indications include:
Respiratory Compromise
- Tachydyspnea, recurrent respiratory infections, or signs of pulmonary hyperperfusion 2
- Ventilator dependence (4 of 8 ventilator-dependent patients were weaned within 1 month post-closure) 4
- Underlying pulmonary abnormalities, particularly bronchopulmonary dysplasia or chronic lung disease 2, 4
Hemodynamic Instability
- Heart failure requiring medical management 2
- Pulmonary hypertension (resolution occurred in 7 of 7 assessable patients post-closure) 4
- Failure to thrive or inability to maintain growth percentile 2, 4
High-Risk Comorbidities
- Prematurity with chronic lung disease (OR = 2.4 for early closure) 5
- Chromosomal abnormalities (OR = 3.4 for closure ≤2 years) 5
- Additional congenital heart defects (OR = 2.6 for early closure) 5
- Congenital diaphragmatic hernia or other conditions compromising respiratory function 2
Contraindications to Closure
- Small ASDs (<5 mm diameter) without RV volume overload and no other risk factors should not be closed 3
- Patients with Eisenmenger physiology or severe irreversible pulmonary arterial hypertension without left-to-right shunt must not undergo closure 3, 1
- Advanced pulmonary vascular obstructive disease is an absolute contraindication 3
Surgical vs. Device Closure Considerations
Device Closure Feasibility
- Device closure is the preferred method for secundum ASDs when anatomically suitable 1
- In infants and toddlers, an ASD size-to-patient weight ratio <1.2 predicts successful percutaneous closure (hazard ratio 9.5) 6
- Absolute patient weight or age alone does not independently predict procedural success 6
Surgical Closure Requirements
- Sinus venosus, coronary sinus, and primum ASDs require surgical closure and cannot be closed percutaneously 3, 1
- Neonates and infants typically require surgical rather than device closure due to size constraints 2, 7
Outcomes of Early Closure
- Clinical improvement occurs in 84% of symptomatic patients under 2 years after closure 4
- Respiratory status improves in 77.3% of those with respiratory symptoms 4
- Normal growth resumes in 62.5% of patients with failure to thrive 4
- Pulmonary hypertension resolves in the majority of cases (11 of 13 children in one series) 2
- Surgical complications are uncommon, with no early or late deaths in multiple series 2, 7
Critical Pitfalls to Avoid
- Do not delay closure in symptomatic infants waiting for the "ideal" age of 4-5 years, as even minor left-to-right shunts are poorly tolerated when lungs are compromised 2
- Do not assume all neonatal ASDs require immediate closure—most isolated ASDs can be managed expectantly unless specific high-risk features are present 2, 5
- Do not overlook the development of irreversible pulmonary vascular changes by delaying closure in infants with pulmonary hypertension 2
- Do not attempt device closure in non-secundum ASDs (primum, sinus venosus, coronary sinus defects) as these require surgical repair 3
- Do not proceed with closure in patients with established Eisenmenger physiology, as this worsens outcomes 3, 1